spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Chronic Low Back Pain 

 HSMN NewsFeed - 19 Sep 2023
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 19 Dec 2022
Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain
Devices FDA Product Launch
 HSMN NewsFeed - 28 Mar 2022
Spine BioPharma Completes Series B Financing
Biopharmaceuticals Orthopaedic Venture Capital
 HSMN NewsFeed - 25 Aug 2020
DiscGenics Raises $50 Million in Series C Funding
Regenerative Medicine Orthopaedic Venture Capital
 HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Biopharmaceuticals
 HSMN NewsFeed - 14 Nov 2018
Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality(TM) (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Sep 2018
TranS1(R) Announces NICE Guidance for Approval of AxiaLIF(R) in the UK's National Health System (NHS)
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 27 Aug 2018
SI-BONE, Inc. Announces France's National Healthcare System Establishes Exclusive Positive Coverage for the Triangular iFuse Implant System(R) for MIS SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 26 Jun 2018
Relievant Announces Completion of $58M Series E Financing to Support US Commercialization
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 24 Apr 2018
AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Mar 2018
Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Jan 2018
SI-BONE, Inc. Announces Blue Cross Blue Shield Association Raises Clinical Evidence Rating for MIS SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 11 Dec 2017
FDA Accepts Biologics License Application (BLA) to Review Galcanezumab for the Prevention of Migraine in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Oct 2017
SI-BONE, Inc. Announces Utah's Public Employees Health Plan (PEHP) Establishes Coverage for the iFuse Procedure(TM) for Minimally Invasive SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 3 Oct 2017
DiscGenics Receives FDA Allowance of IND to Commence Clinical Study of Its Degenerative Disc Disease Therapy
Devices Regenerative Medicine Orthopaedic FDA
 HSMN NewsFeed - 13 Jun 2017
SI-BONE, Inc. Announces FDA Clearance and Full U.S. Commercial Launch of the iFuse-3D(TM) Implant, a Patented, 3D-Printed Next Generation Member of the iFuse Implant System(R)
Devices Neurosurgery Orthopaedic Product Launch
 HSMN NewsFeed - 12 Jun 2017
SI-BONE, Inc. Announces Blue Cross and Blue Shield of Vermont Establishes Positive Coverage Policy for MIS Sacroiliac Joint Fusion
Devices Neurosurgery Orthopaedic Reimbursement
 HSMN NewsFeed - 8 May 2017
SI-BONE, Inc. Announces U.S. Military's TRICARE Now Covers MIS SI Joint Fusion
Devices Neurosurgery Orthopaedic Reimbursement
 HSMN NewsFeed - 13 Apr 2017
Zyga Releases 24-month CT Fusion and Clinical Results for SImmetry SI Joint Fusion with Decortication
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 21 Jul 2016
Relievant Medsystems, Inc. Receives FDA 510(k) Clearance for INTRACEPT(R) for the Relief of Chronic Low Back Pain
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 11 Feb 2016
SI-BONE, Inc. Announces Two Economic Publications Showing iFuse Implant System is Cost Effective and Saves Money
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 9 Mar 2015
SI-BONE, Inc. Announces Publication of INSITE, a Prospective Multicenter Randomized Controlled Trial using iFuse Triangular Implants
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 10 Mar 2014
Mainstay Medical Begins Clinical Trial of ReActiv8(R) for People with Chronic Low Back Pain
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 1 Aug 2013
Intrinsic Therapeutics Announces the Enrollment of the 400th Patient in Landmark Barricaid(R) Randomized Trial
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 1 Mar 2013
Studies Published in Pain Medicine Demonstrate Effectiveness of Minimally-Invasive Cooled Radiofrequency Treatment for Low Back Pain
Devices Orthopaedic
 HSMN NewsFeed - 26 Aug 2011
NUCYNTA(R) ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Aug 2011
Relievant Medsystems Appoints Alex M. DiNello as President and Chief Executive Officer
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 8 Aug 2011
Relievant Medsystems Receives FDA Approval to Begin Pivotal Study to Evaluate the Intracept System for Minimally Invasive Treatment of Chronic Low Back Pain
Devices FDA
 HSMN NewsFeed - 3 Dec 2010
St. Jude Medical Neurostimulation Study Demonstrates Sustained Improvement in Chronic Low Back Pain Symptoms and Quality of Life
Devices Neurology
 HSMN NewsFeed - 16 Mar 2010
Spinal Restoration Initiates Patient Enrollment for Phase III Study of Company's Biostat(R) System
Devices Orthopaedic
 HSMN NewsFeed - 3 Feb 2010
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals
 HSMN NewsFeed - 18 Nov 2009
62-Year-Old Man Becomes First Patient in China Implanted with Rechargeable Neurostimulator for Chronic Pain
Devices
 HSMN NewsFeed - 11 Sep 2009
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
Biopharmaceuticals
 HSMN NewsFeed - 9 Jun 2009
Spinal Restoration Announces the Submission of the Investigational Device Exemption (IDE) Pilot Study Results for the Biostat System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 28 Nov 2008
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Biopharmaceuticals
 HSMN NewsFeed - 25 Aug 2008
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Biopharmaceuticals
 HSMN NewsFeed - 29 May 2008
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Biopharmaceuticals
 HSMN NewsFeed - 13 May 2008
Spinal Restoration, Inc. Receives FDA IDE Approval
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 8 May 2008
New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial
Biopharmaceuticals
 HSMN NewsFeed - 7 Nov 2007
Axiom Worldwide's International Medical Advisory Board Steering Committee Issues Consensus Statement Regarding the Axiom Protocols!
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 15 Oct 2007
Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
Biopharmaceuticals Pain Mangement FDA
 HSMN NewsFeed - 9 Oct 2007
Amicable Settlement Reached Between Axiom Worldwide and Adagen Medical
Devices Orthopaedic Litigation
 HSMN NewsFeed - 10 Jul 2007
Spinal Restoration and Baxter Announce Agreement for Developing Spinal Disc Application
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 1 May 2007
Spinal Restoration Announces Clinical, Scientific and Business Advisory Boards
Devices Orthopaedic Personnel
 HSMN NewsFeed - 21 Mar 2007
Spinal Restoration, Inc. Names Gary E. Sabins as President and CEO
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 9 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 8 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Oct 2006
Cephalon Announces Positive Results for FENTORA(TM) (fentanyl buccal tablet) for Breakthrough Pain in Patients with Chronic Low Back Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 10 Oct 2006
DOV Pharmaceutical, Inc. Announces New Strategic Direction, Bicifadine Clinical Studies Results and Program Updates
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 19

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 19 additional stories matching:
Chronic Low Back Pain
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!